{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:29:34Z","timestamp":1795026574627,"version":"4.10.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Here we describe a retrospective analysis of outcomes in 299 patients who underwent peripheral blood haplo-HCT with PTCy from July 2009 through May 2021 and their association with donor characteristics. Patients had mostly acute leukemias and high or very high DRI. Multivariate analyses were conducted examining OS, NRM, relapse, cytokine release syndrome, acute and chronic GVHD. Donor characteristics included age, sex, relationship, ABO status, CMV status, and HLA match grade. Our analysis revealed increasing donor age was associated with higher NRM (compared to age &lt;30; age 30\u201344 HR, 1.65; <jats:italic>P<\/jats:italic>\u2009=\u20090.110, age &gt;44 HR, 1.80; <jats:italic>P<\/jats:italic>\u2009=\u20090.056) but lower relapse risk (compared to age &lt;30; age 30\u201344 HR, 0.61; <jats:italic>P<\/jats:italic>\u2009=\u20090.034, age &gt; 44 HR, 0.71; <jats:italic>P<\/jats:italic>\u2009=\u20090.132). There were no differences in CRS, aGVHD or cGVHD. We found no difference in outcomes based on the donor-recipient relationship. No differences were found based on HLA match grade or DRB1 match status. Increasing donor age was associated with lower relapse risk but higher NRM, resulting in no difference in OS based on donor age. Other donor factors including relationship (parent\/sibling\/child\/ maternal), CMV status, donor sex, HLA match grade, and DRB1 status were not associated with outcomes.<\/jats:p>","DOI":"10.1038\/s41409-023-01984-8","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T12:03:09Z","timestamp":1682683389000},"page":"855-862","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Impact of donor age and relationship on outcomes of peripheral blood haploidentical hematopoietic cell transplantation"],"prefix":"10.1038","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0629-3214","authenticated-orcid":false,"given":"Aaron","family":"Pruitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"De Togni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Godbole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Slade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7786-4155","authenticated-orcid":false,"given":"Ramzi","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"1984_CR1","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","volume":"26","author":"A D\u2019Souza","year":"2020","unstructured":"D\u2019Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, et al. Current use of and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transpl. 2020;26:e177\u2013e182. https:\/\/doi.org\/10.1016\/j.bbmt.2020.04.013.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1984_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1053\/j.seminhematol.2018.07.005","volume":"56","author":"YJ Chang","year":"2019","unstructured":"Chang YJ, Huang XJ. Is human leukocyte antigen-matched sibling donor transplant always better than haploidentical allograft? Semin Hematol. 2019;56:201\u20138. https:\/\/doi.org\/10.1053\/j.seminhematol.2018.07.005.","journal-title":"Semin Hematol"},{"key":"1984_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3324\/haematol.2016.144139","volume":"102","author":"SR McCurdy","year":"2017","unstructured":"McCurdy SR, Kasamon YL, Kanakry CG, Bola\u00f1os-Meade J, Tsai HL, Showel MM, et al. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide. Haematologica. 2017;102:391\u2013400. https:\/\/doi.org\/10.3324\/haematol.2016.144139.","journal-title":"Haematologica"},{"key":"1984_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/leu.2012.210","volume":"27","author":"N Kr\u00f6ger","year":"2013","unstructured":"Kr\u00f6ger N, Zabelina T, de Wreede L, Berger J, Alchalby H, van Biezen A, et al. Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings. Leukemia. 2013;27:604\u20139. https:\/\/doi.org\/10.1038\/leu.2012.210.","journal-title":"Leukemia"},{"key":"1984_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13045-017-0502-3","volume":"10","author":"YJ Chang","year":"2017","unstructured":"Chang YJ, Wang Y, Liu YR, Xu LP, Zhang XH, Chen H, et al. Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis. J Hematol Oncol. 2017;10:134 https:\/\/doi.org\/10.1186\/s13045-017-0502-3.","journal-title":"J Hematol Oncol"},{"key":"1984_CR6","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.bbmt.2012.06.019","volume":"18","author":"SR Solomon","year":"2012","unstructured":"Solomon SR, Sizemore CA, Sanacore M, Zhang X, Brown S, Holland HK, et al. Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial. Biol Blood Marrow Transpl. 2012;18:1859\u201366. https:\/\/doi.org\/10.1016\/j.bbmt.2012.06.019.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1984_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","volume":"8","author":"PV O\u2019Donnell","year":"2002","unstructured":"O\u2019Donnell PV, Luznik L, Jones RJ, Vogelsang GB, Leffell MS, Phelps M, et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transpl. 2002;8:377\u201386. https:\/\/doi.org\/10.1053\/bbmt.2002.v8.pm12171484","journal-title":"Biol Blood Marrow Transpl"},{"key":"1984_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJMsa1311707","volume":"371","author":"L Gragert","year":"2014","unstructured":"Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N. Engl J Med. 2014;371:339\u201348. https:\/\/doi.org\/10.1056\/NEJMsa1311707","journal-title":"N. Engl J Med"},{"key":"1984_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","volume":"127","author":"C Kollman","year":"2016","unstructured":"Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH, et al. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood. 2016;127:260\u20137. https:\/\/doi.org\/10.1182\/blood-2015-08-663823.","journal-title":"Blood"},{"key":"1984_CR10","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood.v98.7.2043","volume":"98","author":"C Kollman","year":"2001","unstructured":"Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98:2043\u201351. https:\/\/doi.org\/10.1182\/blood.v98.7.2043.","journal-title":"Blood"},{"key":"1984_CR11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1182\/blood.2019001212","volume":"134","author":"J Dehn","year":"2019","unstructured":"Dehn J, Spellman S, Hurley CK, Shaw BE, Barker JN, Burns LJ, et al. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR. Blood. 2019;134:924\u201334. https:\/\/doi.org\/10.1182\/blood.2019001212.","journal-title":"Blood"},{"key":"1984_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41409-019-0499-z","volume":"55","author":"SO Ciurea","year":"2020","unstructured":"Ciurea SO, Al Malki MM, Kongtim P, Fuchs EJ, Luznik L, Huang XJ, et al. The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation. Bone Marrow Transpl. 2020;55:12\u201324. https:\/\/doi.org\/10.1038\/s41409-019-0499-z.","journal-title":"Bone Marrow Transpl"},{"key":"1984_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1182\/bloodadvances.2017014829","volume":"2","author":"SR McCurdy","year":"2018","unstructured":"McCurdy SR, Zhang MJ, St Martin A, Al Malki MM, Bashey A, Gaballa S, et al. Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide. Blood Adv. 2018;2:299\u2013307. https:\/\/doi.org\/10.1182\/bloodadvances.2017014829.","journal-title":"Blood Adv"},{"key":"1984_CR14","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1182\/bloodadvances.2020003922","volume":"5","author":"AE DeZern","year":"2021","unstructured":"DeZern AE, Franklin C, Tsai HL, Imus PH, Cooke KR, Varadhan R, et al. Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide. Blood Adv. 2021;5:1360\u20138. https:\/\/doi.org\/10.1182\/bloodadvances.2020003922.","journal-title":"Blood Adv"},{"key":"1984_CR15","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1182\/bloodadvances.2020001620","volume":"4","author":"J Mariotti","year":"2020","unstructured":"Mariotti J, Raiola AM, Evangelista A, Carella AM, Martino M, Patriarca F, et al. Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy. Blood Adv. 2020;4:3900\u201312. https:\/\/doi.org\/10.1182\/bloodadvances.2020001620.","journal-title":"Blood Adv"},{"key":"1984_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/ajh.24963","volume":"93","author":"J Canaani","year":"2018","unstructured":"Canaani J, Savani BN, Labopin M, Huang XJ, Ciceri F, Arcese W, et al. Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation. Am J Hematol. 2018;93:246\u201353. https:\/\/doi.org\/10.1002\/ajh.24963.","journal-title":"Am J Hematol"},{"key":"1984_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","volume":"124","author":"Y Wang","year":"2014","unstructured":"Wang Y, Chang YJ, Xu LP, Liu KY, Liu DH, Zhang XH, et al. Who is the best donor for a related HLA haplotype-mismatched transplant? Blood. 2014;124:843\u201350. https:\/\/doi.org\/10.1182\/blood-2014-03-563130.","journal-title":"Blood"},{"key":"1984_CR18","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.bbmt.2018.02.005","volume":"24","author":"H Elmariah","year":"2018","unstructured":"Elmariah H, Kasamon YL, Zahurak M, Macfarlane KW, Tucker N, Rosner GL, et al. Haploidentical bone marrow transplantation with post-transplant cyclophosphamide using non-first-degree related donors. Biol Blood Marrow Transpl. 2018;24:1099\u2013102. https:\/\/doi.org\/10.1016\/j.bbmt.2018.02.005.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1984_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.bbmt.2018.01.013","volume":"24","author":"SR Solomon","year":"2018","unstructured":"Solomon SR, Aubrey MT, Zhang X, Piluso A, Freed BM, Brown S, et al. Selecting the best donor for haploidentical transplant: impact of HLA, killer cell immunoglobulin-like receptor genotyping, and other clinical variables. Biol Blood Marrow Transpl. 2018;24:789\u201398. https:\/\/doi.org\/10.1016\/j.bbmt.2018.01.013.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1984_CR20","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1182\/blood.v99.5.1572","volume":"99","author":"JJ van Rood","year":"2002","unstructured":"van Rood JJ, Loberiza FR Jr, Zhang MJ, Oudshoorn M, Claas F, Cairo MS, et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood. 2002;99:1572\u20137. https:\/\/doi.org\/10.1182\/blood.v99.5.1572","journal-title":"Blood"},{"key":"1984_CR21","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1038\/s41409-021-01352-4","volume":"56","author":"Y Ye","year":"2021","unstructured":"Ye Y, Wang M, Malard F, Shi J, Lu Y, Ouyang G, et al. Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysis. Bone Marrow Transpl. 2021;56:2567\u201374. https:\/\/doi.org\/10.1038\/s41409-021-01352-4.","journal-title":"Bone Marrow Transpl"},{"key":"1984_CR22","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood.2021013443","volume":"139","author":"EJ Fuchs","year":"2022","unstructured":"Fuchs EJ, McCurdy SR, Solomon SR, Wang T, Herr MR, Modi D, et al. HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide. Blood. 2022;139:1452\u201368. https:\/\/doi.org\/10.1182\/blood.2021013443.","journal-title":"Blood"},{"key":"1984_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1182\/bloodadvances.2017006429","volume":"1","author":"F Lorentino","year":"2017","unstructured":"Lorentino F, Labopin M, Fleischhauer K, Ciceri F, Mueller CR, Ruggeri A, et al. The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis. Blood Adv. 2017;1:669\u201380. https:\/\/doi.org\/10.1182\/bloodadvances.2017006429.","journal-title":"Blood Adv"},{"key":"1984_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bbmt.2017.10.002","volume":"24","author":"AM Raiola","year":"2018","unstructured":"Raiola AM, Risitano A, Sacchi N, Giannoni L, Signori A, Aquino S, et al. Impact of HLA disparity in haploidentical bone marrow transplantation followed by high-dose Cyclophosphamide. Biol Blood Marrow Transpl. 2018;24:119\u201326. https:\/\/doi.org\/10.1016\/j.bbmt.2017.10.002.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1984_CR25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/sj.bmt.1702875","volume":"27","author":"P Anderlini","year":"2001","unstructured":"Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM, et al. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transpl. 2001;27:689\u201392. https:\/\/doi.org\/10.1038\/sj.bmt.1702875.","journal-title":"Bone Marrow Transpl"},{"key":"1984_CR26","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. Consensus Conference on Acute GVHD Grading. Bone Marrow Transpl. 1995;15:825\u20138. 1994","journal-title":"Bone Marrow Transpl"},{"key":"1984_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transpl. 2015;21:389\u2013401.e381. https:\/\/doi.org\/10.1016\/j.bbmt.2014.12.001.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1984_CR28","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1038\/s41409-021-01403-w","volume":"56","author":"R Abboud","year":"2021","unstructured":"Abboud R, Wan F, Mariotti J, Arango M, Castagna L, Romee R, et al. Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis. Bone Marrow Transpl. 2021;56:2763\u201370. https:\/\/doi.org\/10.1038\/s41409-021-01403-w.","journal-title":"Bone Marrow Transpl"},{"key":"1984_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1200\/JCO.21.02286","volume":"40","author":"CJ Gibson","year":"2022","unstructured":"Gibson CJ, Kim HT, Zhao L, Murdock HM, Hambley B, Ogata A, et al. Donor clonal hematopoiesis and recipient outcomes after transplantation. J Clin Oncol. 2022;40:189\u2013201. https:\/\/doi.org\/10.1200\/JCO.21.02286.","journal-title":"J Clin Oncol"},{"key":"1984_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood-2017-05-781260","volume":"130","author":"J Chen","year":"2017","unstructured":"Chen J, Pan J, Wagner J, Sun M. Differences in allogeneic product T-cell subsets according to donor age: associations with immune reconstitution and acute graft versus host disease (aGVHD) in haploidentical (HI) hematopoietic stem cell transplant (HSCT). Blood. 2017;130:1.","journal-title":"Blood"},{"key":"1984_CR31","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1189\/jlb.0907627","volume":"84","author":"R Simone","year":"2008","unstructured":"Simone R, Zicca A, Saverino D. The frequency of regulatory CD3+CD8+CD28- CD25+T lymphocytes in human peripheral blood increases with age. J Leukoc Biol. 2008;84:1454\u201361. https:\/\/doi.org\/10.1189\/jlb.0907627.","journal-title":"J Leukoc Biol"},{"key":"1984_CR32","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nm1326","volume":"11","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Host-reactive CD8+memory stem cells in graft-versus-host disease. Nat Med. 2005;11:1299\u2013305. https:\/\/doi.org\/10.1038\/nm1326.","journal-title":"Nat Med"},{"key":"1984_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4049\/jimmunol.1001505","volume":"186","author":"CA Chougnet","year":"2011","unstructured":"Chougnet CA, Tripathi P, Lages CS, Raynor J, Sholl A, Fink P, et al. A major role for Bim in regulatory T cell homeostasis. J Immunol. 2011;186:156\u201363. https:\/\/doi.org\/10.4049\/jimmunol.1001505.","journal-title":"J Immunol"},{"key":"1984_CR34","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1182\/blood-2014-11-608406","volume":"125","author":"A Roberto","year":"2015","unstructured":"Roberto A, Castagna L, Zanon V, Bramanti S, Crocchiolo R, McLaren JE, et al. Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation. Blood. 2015;125:2855\u201364. https:\/\/doi.org\/10.1182\/blood-2014-11-608406.","journal-title":"Blood"},{"key":"1984_CR35","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbmt.2009.11.011","volume":"16","author":"YL Kasamon","year":"2010","unstructured":"Kasamon YL, Luznik L, Leffell MS, Kowalski J, Tsai HL, Bola\u00f1os-Meade J, et al. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transpl. 2010;16:482\u20139. https:\/\/doi.org\/10.1016\/j.bbmt.2009.11.011.","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-023-01984-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-023-01984-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-023-01984-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T08:03:10Z","timestamp":1691049790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-023-01984-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1984"],"URL":"https:\/\/doi.org\/10.1038\/s41409-023-01984-8","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"24 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}